HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 116 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,866,283 | +123981.8% | 1,644,999 | -12.3% | 0.05% | – |
| Q2 2023 | $22,458 | -99.9% | 1,874,786 | -12.9% | 0.00% | -100.0% |
| Q1 2023 | $28,018,220 | -13.2% | 2,151,937 | -1.4% | 0.05% | -20.6% |
| Q4 2022 | $32,263,705 | +106.7% | 2,182,930 | +23.9% | 0.06% | +96.9% |
| Q3 2022 | $15,609,000 | -3.0% | 1,761,689 | +38.3% | 0.03% | +113.3% |
| Q2 2022 | $16,097,000 | -41.6% | 1,273,504 | -12.6% | 0.02% | -28.6% |
| Q1 2022 | $27,576,000 | -50.3% | 1,457,524 | -7.8% | 0.02% | -46.2% |
| Q4 2021 | $55,445,000 | -12.0% | 1,580,538 | -8.1% | 0.04% | -20.4% |
| Q3 2021 | $62,983,000 | -16.9% | 1,720,359 | -10.9% | 0.05% | -23.4% |
| Q2 2021 | $75,812,000 | +58.1% | 1,930,537 | +13.7% | 0.06% | +39.1% |
| Q1 2021 | $47,949,000 | -8.9% | 1,697,298 | +3.2% | 0.05% | -11.5% |
| Q4 2020 | $52,644,000 | +16.0% | 1,644,082 | +17.0% | 0.05% | -1.9% |
| Q3 2020 | $45,389,000 | +9.5% | 1,405,242 | -6.5% | 0.05% | +10.4% |
| Q2 2020 | $41,454,000 | +81.7% | 1,503,042 | +17.6% | 0.05% | +54.8% |
| Q1 2020 | $22,809,000 | +24.3% | 1,277,842 | +74.6% | 0.03% | +82.4% |
| Q4 2019 | $18,347,000 | +38.5% | 731,842 | -1.4% | 0.02% | +30.8% |
| Q3 2019 | $13,246,000 | -10.8% | 742,476 | +10.0% | 0.01% | -7.1% |
| Q2 2019 | $14,847,000 | -19.5% | 674,876 | +11.9% | 0.01% | -22.2% |
| Q1 2019 | $18,446,000 | +78.5% | 603,194 | +34.8% | 0.02% | +63.6% |
| Q4 2018 | $10,333,000 | -28.3% | 447,494 | 0.0% | 0.01% | -15.4% |
| Q3 2018 | $14,405,000 | +57.4% | 447,494 | +47.3% | 0.01% | +44.4% |
| Q2 2018 | $9,154,000 | +30.1% | 303,729 | +27.6% | 0.01% | +28.6% |
| Q1 2018 | $7,034,000 | +1.8% | 237,973 | +35.8% | 0.01% | +40.0% |
| Q4 2017 | $6,910,000 | +94.1% | 175,300 | -41.4% | 0.01% | +66.7% |
| Q3 2016 | $3,560,000 | -23.0% | 299,200 | -14.9% | 0.00% | -40.0% |
| Q2 2016 | $4,621,000 | +5.3% | 351,400 | +5.7% | 0.01% | 0.0% |
| Q1 2016 | $4,388,000 | – | 332,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |